The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Consulting or Advisory Role - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Research Funding - Bayer/Onyx; Bristol-Myers Squibb; Genentech; Merck
Travel, Accommodations, Expenses - Bayer/Onyx; Bristol-Myers Squibb; Exelixis; Merck
 
Roberto Carmagnani Pestana
No Relationships to Disclose
 
Luis M. Vence
No Relationships to Disclose
 
Jorge M. Blando
No Relationships to Disclose
 
Shalini Singh
No Relationships to Disclose
 
Naruhiko Ikoma
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
Honoraria - Bayer; Eisai
Consulting or Advisory Role - Bayer (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Divya Sakamuri
No Relationships to Disclose
 
Lauren Girard
No Relationships to Disclose
 
Dongfeng Tan
No Relationships to Disclose
 
Jean-Nicolas Vauthey
No Relationships to Disclose
 
Ching-Wei David Tzeng
No Relationships to Disclose
 
Thomas A. Aloia
No Relationships to Disclose
 
Yun Shin Chun
No Relationships to Disclose
 
James C. Yao
No Relationships to Disclose
 
Robert A. Wolff
Honoraria - Precision Medicine Research Associates, LLC
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
James Patrick Allison
Patents, Royalties, Other Intellectual Property - Inventor of a patent held by the University of California, Berkeley, and licensed to Bristol Meyers-Squibb; Inventor of a patent owned by Memorial Sloan-Kettering Cancer Center and licensed by Jounce Therapeutics
 
Padmanee Sharma
Stock and Other Ownership Interests - Apricity Health; Apricity Health (I); BioAtla; BioAtla (I); Codiak Biosciences; Codiak Biosciences (I); Constellation Pharmaceuticals; Forty Seven; Forty Seven (I); Hummingbird; Hummingbird (I); ImaginAb; ImaginAb (I); Jounce Therapeutics; Jounce Therapeutics (I); Marker Therapeutics; Marker Therapeutics (I); Neon Therapeutics; Neon Therapeutics (I); Oncolytics; Polaris; Polaris (I); TapImmune Inc.; TapImmune Inc. (I); Tvardi Therapeutics (I)
Consulting or Advisory Role - Amgen (I); Apricity Health; Apricity Health (I); BioAtla; BioAtla (I); Bristol-Myers Squibb (I); Codiak Biosciences; Codiak Biosciences (I); Constellation Pharmaceuticals; Forty Seven; Forty Seven (I); Hummingbird; Hummingbird (I); ImaginAb; ImaginAb (I); Jounce Therapeutics; Jounce Therapeutics (I); Marker Therapeutics; Marker Therapeutics (I); Merck; Merck (I); Neon Therapeutics; Neon Therapeutics (I); Oncolytics; Pieris Pharmaceuticals; Polaris; Polaris (I); TapImmune Inc.; TapImmune Inc. (I); Tvardi Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)